Nov./Dec. 2002

Brand Champions

January 18, 2010

The role of the is being played by branding companies, advertising agencies,by the companies that are in charge of producing materials and giving strategic advice to pharmaceutical companies.There are few companies that have a brand champion. Vince Parry TOO OFTEN BRANDING IS MISTAKEN FOR AN ADVERTISING CAMPAIGN, WHEN IN REALITY BRANDING SHOULDBEVIEWED AS CREATINGALASTINGBOND WITH […]

Dr. Alan E. Guttmacher — In the genes

January 18, 2010

AS THE RECENTLY APPOINTED SECOND DEPUTY DIRECTOR OF THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE,THE INSTITUTION RESPONSIBLE FOR LEADING THE HUMAN GENOME PROJECT, DR.ALAN GUTTMACHER’S EXTENSIVE CLINICAL GENETICS BACKGROUND WILL BE INVALUABLE AT A TIME WHEN RESEARCHERS ARE BEGINNING TO TRANSLATE THE INFORMATION CONTAINED IN THE NEARLY COMPLETED HUMAN GENOME SEQUENCE INTO MEDICAL ADVANCES. In the […]

No Pain, Big Gain

January 18, 2010

Daily injections are a painful way of life for an estimated 3.7 mil lion Americans who are insulin dependent diabetics. The condi tion, characterized by high blood sugar levels that result from defects in the body’s ability to produce and/or use insulin, is the fifth leading cause of death by disease in the U.S., and […]

The Package Deal

January 18, 2010

PharmaVOICE Container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, pro cessor, packer, or distributor other than the per son or persons who in fact manufactured, pro cessed, packed, or distributed such drug and which thereby falsely […]

The Patient Pipeline

January 18, 2010

CLINICAL TRIAL RECRUITMENT AND ENROLLMENT EFFORTS ARE OFTEN NOT GIVEN HIGH PRIORITY, causing costly delays in the develop ment of new drugs. Unfortunately, there are no quick fixes, but companies are beginning to institute wellthought out and designed processes to bring the right patients to the right trials. Industry analysts intimate that one of the […]

Talent Pool

January 14, 2010

Pharma POOL Mark BOOTH Takeda Pharmaceuticals North America Names President Takeda Pharmaceuticals North America Inc. (TPNA), a wholly owned subsidiary of Takeda Chemical Industries Ltd., has restructured its senior executive team and named Mark Booth president. Mr. Booth, an 18year veteran of the healthcare industry, has management respon sibility for all aspects of TPNA’s business, […]

E-Media

January 14, 2010

E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES FDAnews has launched Drug Industry Daily, an electronic daily publication that provides news coverage of what’s happening on Capitol Hill, in the courts, and at the Food and Drug Administration, the Federal Trade Commission, the Department of Health and Human Services, the National Institutes of Health, […]

What’s New

January 14, 2010

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Doctors+Designers has changed its company name to HealthEd to reflect a change in business strategy focusing on developing patient-centered health education programs. “With noncompliance costing the pharmaceuti cal industry $15 billion to $20 billion each year, according to the National Pharmaceutical Council, the need for patientcentered health education is […]

PharmaTrax

January 14, 2010

SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY NestEggz Survey Suggests PATIENTS WHO SAVE ON PRESCRIPTIONS TAKE THEIR MEDICATION Almost 90% of cholesterol patients enrolled in NestEggz were found to take their medication daily, almost double the national average.NestEggz,a loyal ty and relationshipmarketing program for the phar maceutical industry, was created by Nuvisio Corp. […]

For Art’s Sake

January 14, 2010

Catchy, creative, and memorable are three words to describe this month’s selection of standout creative executions. Two of the ad campaigns, Viagra and Glucotrol XL, were executed by Cline, Davis &Mann on behalf of client Pfizer Inc. The first of the ads was cre ated for the launch of Viagra. The creative team positioned the […]

Pharma Outlet

January 14, 2010

For the first time since the Food and Drug Administration lessened restrictions on direct to consumer pharmaceutical advertisements in 1996, there is a significant slowing in direct to consumer advertising expenditures. From 1996 to 2000, directtoconsumer advertising spending grew more than threefold from $791 million to $2.5 billion. In 2001, spending increased a very modest […]

What’s on Your Mind: Opinions

January 14, 2010

The economy In my opinion, the biggest impact on the industry has been the fallout from the economic downturn. A climate of near paralysis has seized much of the industry and I don’t expect that climate to change much until well into 2003. The uncertainty of the timing of the eco nomic turnaround has resulted […]

Raise your voice: Letters

January 14, 2010

Turn up the volume Each month, our team looks forward to what’s inside the next issue of PharmaVoice. It’s fresh, uncanny in its timeliness, and always relevant. (Like us.) Evenhanded panels of industry experts help us weigh the issues that are going to matter, and the statistics are so fresh that we can actually use […]

Letter from the Editor

January 14, 2010

PharmaVOICE A product lives on a shelf. A brand lives in the mind of the consumer . The challenge, according to industry experts, is making an emotional connection between the two. A brand goes beyond the rational; a brand is the promise the product offers the customer or stakeholder, whether that customer is a physician, […]

FEEDBACK